FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...